Northstar Investment Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$284K Hold
2,001
0.04% 141
2021
Q1
$257K Sell
2,001
-599
-23% -$73.8K 0.04% 138
2020
Q4
$310K Hold
2,600
0.05% 122
2020
Q3
$298K Hold
2,600
0.05% 115
2020
Q2
$296K Hold
2,600
0.06% 116
2020
Q1
$209K Hold
2,600
0.05% 115
2019
Q4
$278K Hold
2,600
0.04% 124
2019
Q3
$266K Buy
+2,600
New +$267K 0.04% 119

Other funds holding DGX

Northstar Investment Advisors's DGX Position: Q2 2021 in Review

Northstar Investment Advisors held its Quest Diagnostics (DGX) position steady in Q2 2021 at 2,001 shares worth $284K. The position accounts for 0.04% of the portfolio, ranked #141.

Northstar Investment Advisors first reported a position in DGX in Q3 2019 and has held it in 8 quarters since. The position peaked at $310K in Q4 2020. 814 funds tracked by Wall St. Rank hold DGX as of Q2 2021.

  • Northstar Investment Advisors held 2,001 shares of Quest Diagnostics worth $284K as of Q2 2021.
  • Northstar Investment Advisors left its Quest Diagnostics share count unchanged in Q2 2021.
  • Quest Diagnostics made up 0.04% of Northstar Investment Advisors's portfolio in Q2 2021, its #141 holding.
  • Northstar Investment Advisors first reported a position in Quest Diagnostics in Q3 2019 and has held it in 8 quarters since.
  • Northstar Investment Advisors's Quest Diagnostics position peaked at $310K in Q4 2020.
  • 814 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2021.

Based on Northstar Investment Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.